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ClostridiumsordelliiandClostridiumperfringensareinfrequenthumanpathogens;however,thecase-fatalityratesfortheinfections
are very high, particularly in obstetric C. sordellii infections (>90%). Deaths from Clostridium sordellii and Clostridium perfringens
toxic shock (CTS) are sudden, and diagnosis is often challenging. Formalin-ﬁxed, paraﬃn-embedded (FFPE) tissues usually are
the only specimens available for sudden fatal cases, and immunohistochemistry (IHC) for Clostridia is generally performed but it
cannot identify species. A clear need exists for a rapid, species-speciﬁc diagnostic assay for FFPE tissues. We developed a duplex
PCR-based microsphere assay for simultaneous detection of C. sordellii and C. perfringens and evaluated DNA extracted from 42
Clostridium isolates and FFPE tissues of 28 patients with toxic shock/endometritis (20CTS, 8non-CTS, as conﬁrmed by PCR and
sequencing). The microsphere assay correctly identiﬁed C. sordellii and C. perfringens in all known isolates and in all CTS patients
(10C.sordellii,8C.perfringens,2both)andshowed100%concordancewithPCRandsequencingresults.Themicrosphereassayis
a rapid, speciﬁc, and cost-eﬀective method for the diagnosis of CTS and oﬀers the advantage of simultaneous testing for C. sordellii
and C. perfringens in FFPE tissues using a limited amount of DNA.
1.Introduction
ClostridiumspeciesareubiquitousGram-positive,anaerobic,
spore-forming bacteria that are generally found in soil
and in the intestinal tract of humans and other animals.
Clostridium sordellii has been reported to cause a variety
of diseases including peritonitis, endocarditis, pneumonia,
arthritis, cellulitis, and myonecrosis [1–4]. Fulminant toxic
shock syndrome and sepsis among previously healthy per-
sons have been described most often in cases associated
with gynecologic infections and neonatal omphalitis [3, 5].
Clostridium perfringens is also responsible for a number
of clinical conditions in humans ranging from acute food
poisoning and enteritis to gas gangrene, enterotoxemia, and
endometritis [6–8]. In the last couple of years, several studies
reported pregnancy-associated fatal toxic shock syndrome
cases due to C. sordellii and C. perfringens infections [8–10].
Among all C. sordellii infections reported in the literature,
the overall case fatality ratio is 70%, while, for obstetric
infections, it is more than 90% [8]. Pregnancy-associated
C. perfringens fulminant septicemia also carries a very high
mortality rate [8]. Deaths from C. sordellii and C. perfringens
toxic shock (CTS) are sudden, and most patients die from
hypotension and multiorgan failure within hours to a few
days after the initial presentation.
A presumptive clinical diagnosis of CTS can be chal-
lenging and often confounded by nonspeciﬁc symptoms, an
absence of fever, and the low prevalence of these infections2 Infectious Diseases in Obstetrics and Gynecology
[10]. A conﬁrmatory diagnosis can only be performed
by conventional microbiological isolation and character-
ization methods including bacterial culture, biochemical
analysis, or enzyme-linked immunosorbent (ELISA) assay.
However, the fastidious anaerobic growth, variable stain-
ing characteristics, and complex biochemical proﬁles of
Clostridium species make them diﬃcult to isolate [11, 12].
In addition, for the fatal cases, involving sudden death,
unavailability of appropriate specimens in adequate amount
poses further challenge. Formalin-ﬁxed, paraﬃn-embedded
(FFPE), archival autopsy or biopsy tissues are often the
only specimens available for the fatal cases, and they are
unsuitableformicrobialmethods.ForFFPEtissues,generally
tissue-based diagnostic methods such as histopathology,
special stains, and immunohistochemistry (IHC) are used;
however, these methods cannot identify speciﬁc Clostridium
species.
In the last couple of years, we reported detection of
C. sordellii and C. perfringens in FFPE tissues of several
fatal obstetrical cases using the conventional, agent-speciﬁc
toxin genes PCR assays and sequencing [8–10]. These
assays can identify species; however, the conventional PCRs
and sequencing can be time-consuming, laborious, and
expensive. In addition, to perform multiple conventional
PCR assays, an adequate amount of patient specimen is
required, which is often limiting in cases of sudden death.
All the above-mentioned factors highlighted the need to
develop a rapid, sensitive, and speciﬁc multiplex diagnostic
assay such as multiplex PCR. However, traditional multiplex
PCR/real time PCR can be challenging because ampliﬁcation
conditions for multiple targets are often incompatible and
the combination of several primers, probes, and reagents
in a single reaction generally results in loss of sensitivity
and speciﬁcity for each of the individual target species. In
addition, primer dimer formation and spectral overlap of
ﬂuorescent labels when using TaqMan or Molecular Beacons
may compromise the ability to interpret quantitative data
[13]. Luminex xMAP (multianalyte proﬁling) technology
(LuminexCorp.,Austin,TX)addressestheseissuesviaappli-
cation of microsphere-based suspension arrays and allows
for multiplexing. Multiplexed microsphere-based detection
of bacteria using the Luminex platform has been described
previously [14, 15].
The objective of this study was to develop a rapid duplex
PCR-based microsphere assay that can simultaneously detect
C. sordellii and C. perfringens in diﬀerent clinical specimens,
including FFPE tissues, and to evaluate its application as
a potential diagnostic tool for pregnancy-associated toxic
shock syndrome cases in comparison with other tissue-based
diagnostic methods, including IHC and conventional PCR.
2.MaterialsandMethods
2.1. Samples. DNA was extracted from various Clostridium
isolates (n = 42) and FFPE tissues of patients with toxic
shock/necrotizing endometritis (n = 28) and evaluated
by the duplex PCR-based microsphere assay for C. sordellii
and C. perfringens. DNA samples of 42 known Clostridium
isolates were obtained from the Laboratory Branch, Divi-
sion of Healthcare Quality Promotion, Centers for Disease
Control and Prevention (CDC). All 28 cases were submitted
to the Infectious Diseases Pathology Branch (IDPB), CDC,
from 2004 to 2009 for diagnostic consultation. Clinical
and demographic information on the cases were collected
when available from medical records. For the conﬁrmation,
identiﬁcation of all the isolates and diagnosis of all the cases
were also performed by conventional diagnostic methods.
Clinical information as well as conventional diagnostic assay
(PCR, sequencing and IHC) results of all C. sordellii and all
except 2 C. perfringens cases were previously published as
case reports by our group, and, in this study, these cases were
used for validation of the microsphere assay [8–10, 16].
2.2. Conventional Diagnostic Methods. DNA was extracted
from FFPE tissues of all the cases using the QIAamp
DNA mini kit (QIAGEN) following the tissue extraction
protocol as previously described [18]. The DNA samples
were evaluated by C. sordellii and C. perfringens speciﬁc
conventional PCR assays targeting the lethal toxin and alpha
toxin genes and sequencing, as we described before [8].
To monitor the quality of extraction and to verify the
presence of ampliﬁable DNA, samples were also tested for
the ampliﬁcation of the house-keeping gene human beta-
globin [19]. FFPE tissues of all the cases were analyzed
by routine hematoxylin-eosin (H&E) and special stains to
evaluate histopathological changes and IHC for Clostridia
species was performed to localize Clostridia antigens in
deparaﬃnized, rehydrated 3µm sections of tissue samples,
as we described previously [20]. For the diagnosis of C.
sordellii and C. perfringens PCR and IHC negative cases, PCR
and/orIHCassaysforothersuspectbacterialagentswerealso
performed [20–25].
2.3. PCR-Based Microsphere Assay
2.3.1.PCRPrimers,OligonucleotideCaptureProbes,andProbe
Coupling to Microspheres. The primers, probes sequences,
genetargets,andampliﬁcationproductsizesaresummarized
in Table 1. The primers and probes were synthesized in
the Biotechnology Core Facility, CDC, Atlanta, GA. The
reverse primers were biotinylated. The probe sequences were
labeled at the 5 end with an amino-modiﬁed 6-carbon
linker and covalently conjugated to individual carboxylated
microspheres (Luminex Corp., Austin, TX) using a car-
bodiimide coupling procedure [26]. A Beckman Coulter Z2
(Hialeah, FL) was used to count conjugated microsphere
stockstodetermineconcentration.Conjugatedmicrospheres
were stored in the dark at 4◦Ci nT Eb u ﬀer. For each
probe, a corresponding 5  biotinylated, complementary
oligonucleotide was designed for testing the speciﬁcity and
eﬀectiveness of microsphere-probe conjugation.
2.3.2. PCR Ampliﬁcation. DNA samples of all the cases and
isolates were evaluated by the microsphere assay. Initially,
phospholipase C genes of C. sordellii and C. perfringens were
ampliﬁed using a High Fidelity PCR Kit (Roche), 0.3µMo fInfectious Diseases in Obstetrics and Gynecology 3
Table 1: Oligonucleotide primers and probes used in the duplex microsphere assay.
Primer Sequence (5 -3 )G e n e t a r g e t Product
size (bp)
Clostridium sordellii primers and
probes
CSP09-F primer TGG GAT GAT TGG GAT TAT TCAG Phospholipase C of C. sordellii (Csp)
176 bp CSP09-BR primer TCA GTT CCT GCA TAT TCA TTG T Phospholipase C of C. sordellii (Csp)
CSP09 probe AGA AGC GAT AAA AAA TTC TCA A Phospholipase C of C. sordellii (Csp)
Clostridium perfringens primers
[17]a n dp r o b e s
PL3-F primer AAG TTA CCT TTG CTG CAT AAT CCC Phospholipase C of C. perfringens (plc)
283bp PL7-BR primer ATA GAT ACT CCA TAT CAT CCT GCT Phospholipase C of C. perfringens (plc)
CP1 probe TTT AGC AAA ACC TCT TG Phospholipase C of C. perfringens (plc)
each primer (ﬁnalconcentration), and 5µLo ft e m p l at eD N A
sample in a 50µL ﬁnal reaction volume, following the man-
ufacturer’s instructions. Ampliﬁcation was carried out on a
GeneAmp 9700 thermocycler (Applied Biosystems), using
the following cycle conditions: 94◦C/2minutes; 35 cycles of
94◦C/20 seconds, 60◦C/30 seconds, and 72◦C/30 seconds,
followed by a ﬁnal extension of 72◦C/5minutes.
2.3.3. Hybridization of PCR Amplicons to Microsphere Conju-
gated Probes and Detection. For hybridization, nonpuriﬁed
biotinylated PCR products were hybridized to the probe-
microspherecomplexesunderoptimized reactionconditions
in a 96 conical well PCR plate (Costar no. 6509). Each
sample was run in triplicate with six reaction blanks
per plate. The probe-conjugated microspheres were pulse-
vortexed and sonicated for at least 40seconds, and a working
microsphere mixture was prepared by adding calculated
volumes of both sets of conjugated microspheres (C. sordellii
and C. perfringens)t o1 . 5 XT M A Cb u ﬀer (4.5M tetramethyl
ammoniumchloride,75mMTris-HCl,pH8.0,6mMEDTA,
and 0.15% sarkosyl) to achieve a concentration of 1500
microspheres per set per well.
In each sample well of the PCR plate, 30µLo fm i c r o -
sphere mix and 20µLo fs a m p l em i x ,c o m p o s e do f1 – 5µL
biotinylated PCR ampliﬁcation product in TE buﬀer (pH
8.0), were added. Reaction blanks contained only micro-
sphere mix and TE buﬀer. The PCR plate was covered, and
incubated in a thermocycler at 95◦C for 5minutes, followed
by 48◦C for 30minutes. After incubation, the reactions were
transferred to a ﬁlter plate and washed two times with 1X
TMAC buﬀer using a vacuum manifold. Reporter mixture
that contained a fresh 1:100 dilution of streptavidin-R-
phycoerythrin (SA-PE; Molecular Probes, Eugene, OR) in
1X TMAC buﬀer was added to each well (75µL), carefully
mixed by hand pipetting and transferred to a PCR plate. The
plate was covered, and the samples were heated to 48◦Cf o r
15minutes and analyzed at 48◦C on the Bio-Plex 200 system.
BioPlex Manager Software v. 5.0 (Bio-Rad Hercules, CA) was
used for data acquisition. The hybridization of biotinylated
PCR amplicons to the probe sequences on the respective
microspherepopulationsgeneratedtheMedianFluorescence
Intensity (MFI), which represented the SA-PE ﬂuorescence
of 100 biotinylated amplicon-bound microspheres. The re-
ported signal for each probe was obtained by subtracting the
mean MFI of the blanks from the MFI values of the samples.
The MFI value greater than 4 times the mean MFIs of the
negative control isolates was designated as the cut-oﬀ value
for positive signal detection.
3. Results
Organism speciﬁc PCR and sequencing identiﬁed C. sordellii
in 10 cases, C. perfringens in 8 cases, and mixed infection of
C. sordellii and C. perfringens in 2 cases of CTS. In the non-
CTS cases, PCR and/or IHC assays detected C. diﬃcile in
2 cases and Streptococcus pyogenes, Streptococcus agalactiae,
Staphylococcus aureus, Neisseria meningitides, Neisseria gon-
orrhoeae,o rBacillus cereus was identiﬁed in one case each.
Demographic and clinical information, pathologic ﬁndings,
results of conventional diagnostic assays, including organism
speciﬁc PCR, sequencing, and IHC assay, and the duplex
microsphere assay for all the CTS cases are listed in Table 2.
The mean age for the C. sordellii patients was 24 years
and 33 years for the C. perfringens patients. All cases, except
one C. sordellii case, were fatal. Of 10 C. sordellii cases, 8
were medical abortion cases, 1 was a spontaneous abortion
case, and 1 had no pregnancy association but was associated
with a gynecological procedure. Of 8 C. perfringens cases, 3
were medical abortion, 4 were postpartum cases, and 1 was
a spontaneous abortion case. Of 42 isolates included in the
study, 9 each were isolates of C. sordellii and C. perfringens
and 24 were various other Clostridium species isolates (4 C.
diﬃcile and 5 each C. butyricum, C. septicum, C. sporogenes,
C. tetani), as conﬁrmed by conventional diagnostic assays.
The duplex microsphere assay correctly identiﬁed C.
sordellii and C. perfringens in all 18 known isolates of C.
sordellii and C. perfringens (9 each). All 24 other Clostridia
isolates were negative by the assay (Table 3). Figure 1 shows
the MFI readings for the C. sordellii and C. perfringens iso-
lates. The MFI readings for non-clostridia isolates (negative
controls) ranged from 0 to 58. Thus, the microsphere assay
showed 100% analytical speciﬁcity for C. sordellii and C.
perfringens. The detection limits of the microsphere and
conventionalPCRassaysweredeterminedbypreparingserial4 Infectious Diseases in Obstetrics and Gynecology
Table 2: Demographic, clinicopathological ﬁndings, and case-by-case comparison of IHC, PCR, and microsphere assay results.
Case no. Age
Association
with
pregnancy
Outcome Tissue tested Pathological
ﬁndings
Clostridia
IHC
C. sordellii
PCR
C.
perfringens
PCR
Microsphere assay
11 8 Medical
abortion Fatal Uterus Necrotizing
endomyometritis Positive Positive Negative Positive for C.
sordellii
22 2 Medical
abortion Fatal Uterus Necrotizing
endomyometritis Positive Positive Negative Positive for C.
sordellii
33 4 Medical
abortion Fatal Uterus Necrotizing
endomyometritis Positive Positive Negative Positive for C.
sordellii
42 1 Medical
abortion Fatal Uterus Necrotizing
endomyometritis Positive Positive Negative Positive for C.
sordellii
52 6 Medical
abortion Fatal Endometrium Necrotizing
endomyometritis Positive Positive Negative Positive for C.
sordellii
62 5 Spontaneous
abortion Non-fatal Placenta Severe acute
chorioamnionitis Positive Positive Negative Positive for C.
sordellii
7 32 No association Fatal Uterus Necrotizing
endometritis Positive Positive Negative Positive for C.
sordellii
81 8 Medical
abortion Fatal Unknown Necrotizing
endometritis Positive Positive Negative Positive for C.
sordellii
92 9 Medical
abortion Fatal Uterus Necrotizing
endometritis Positive Positive Negative Positive for C.
sordellii
10 21 Medical
abortion Fatal
Decidual and
chorionic
tissue
Acute
inﬂammation
and necrosis
Positive Positive Negative Positive for C.
sordellii
11 24 Medical
abortion Fatal Uterus Necrotizing
endomyometritis Positive Negative Positive Positive for C.
perfringens
12 28 Medical
abortion Fatal Uterus Necrotizing
endomyometritis Positive Negative Positive Positive for C.
perfringens
13 40 Postpartum Fatal Uterus Acute
endomyometritis Positive Negative Positive Positive for C.
perfringens
14 41 Postpartum Fatal Uterus Necrotizing
endometritis Positive Negative Positive Positive for C.
perfringens
15 37 Medical
abortion Fatal Uterus Necrotizing
endometritis Negative Negative Positive Positive for C.
perfringens
16 26 Postpartum Fatal Uterus
Necrotic and
hemorrhagic
uterus
Negative Negative Positive Positive for C.
perfringens
17 41 Spontaneous
abortion Fatal Uterus Endomyometritis
and sepsis Positive Negative Positive Positive for C.
perfringens
18 32 Postpartum Fatal GI Necrotizing
enteritis Positive Negative Positive Positive for C.
perfringens
19 16 Medical
abortion Fatal Appendix
Acute
appendicitis and
peritonitis
Positive Positive Positive Positive for both
20 40 No association Fatal Cervix Acute cervicitis
and endometritis Positive Positive Positive Positive for both
dilutions of C. sordellii and C. perfringens isolate DNA for
testing by the assays. The detection limit for the conventional
PCR assays was 2ng/µL for the starting DNA sample, while
the detection limit of microsphere assay was 1.4ng/µL.
Thus, clinical sensitivity of the duplex microsphere assay
was slightly higher than the single-plex conventional PCR
assays.
The microsphere assay also accurately detected C. sor-
dellii and C. perfringens in FFPE tissues of all conﬁrmed
CTS cases (10 C. sordellii,8C. perfringens) as summarized
in Tables 2 and 4. Figure 2 shows the MFI readings of
these CTS cases. The assay was also able to identify both C.
sordellii and C. perfringens in 2 mixed infection cases. FFPE
tissues from 8 patients with non-CTS bacterial infections
were negativewith MFI readings ranging from 0 to 23. These
results demonstrate that the microsphere assay was 100%
concordant with the conventional PCR and sequencing
results.Infectious Diseases in Obstetrics and Gynecology 5
Table 3: Microsphere assay results of Clostridium species isolates.
Clostridium species Number of
isolates tested
Number of positive isolates
For C. sordellii For C. perfringens
Clostridium sordellii 9 9/9 (100%) 0/9 (0%)
Clostridium perfringens 9 0/9 (0%) 9/9 (100%)
Clostridium diﬃcile 4 0/4 (0%) 0/4 (0%)
Clostridium butyricum 5 0/5 (0%) 0/5 (0%)
Clostridium septicum 5 0/5 (0%) 0/5 (0%)
Clostridium sporogenes 5 0/5 (0%) 0/5 (0%)
Clostridium tetani 5 0/5 (0%) 0/5 (0%)
Table 4: Microsphere, PCR, and IHC assay results of CTS cases.
Clostridium cases
(no. of cases)
Positive for C. sordellii Positive for C. perfringens
IHC∗ PCR∗∗ Microsphere
assay IHC∗ PCR∗∗ Microsphere
assay
C. sordellii (n = 10) 10 10 10 10 0 0
C. perfringens (n = 8) 6 0 0 6 8 8
C. sordellii and
C. perfringens
coinfection (n = 2)
22 2 2 2 2
∗IHC assay is speciﬁc for Clostridia but cannot speciate further.
∗∗Conventional PCR assay targeting the phospholipase C gene of C. sordellii and C. perfringens.
The Clostridium IHC was positive in all except for 2
C. perfringens cases. Figure 3(a) illustrates the hemorrhage,
inﬂammation, and necrosis of the endometrium and abun-
dant Gram-positive bacilli in a positive C. sordellii case. IHC
also detected Clostridial antigens inside the inﬂammatory
cells present in the necrotic endometrial tissues (Figure 3(b))
and in myometrial blood vessels of the positive CTS cases.
4. Discussion
This study describes the development of a duplex PCR-based
microsphere assay using a suspension array technology, the
Luminex xMAP, for rapid, simultaneous detection of C.
sordellii and C. perfringens. Although DNA assays developed
on the Luminex platform have been used for identiﬁcation
and genotyping of infectious agents such as Mycobacterium,
Escherichia coli, Salmonella, Cryptosporidium, Listeria, Can-
dida, and various respiratory bacteria and viruses [14,
15, 26–29] in serum and other clinical specimens, to our
knowledge, this represents the ﬁrst report of the application
ofthistechnologyforthediagnosisofClostridiuminfections,
particularly in the FFPE archival tissues. This duplex micro-
sphere assay can have important implications for the pre-
mortem and postmortem diagnosis of pregnancy-associated
CTS cases.
In recent years, C. sordellii and C. perfringens have been
found to be associated with severe or fatal toxic shock
syndrome in both postpartum and postabortive women
[8–10]. Although pregnancy and gynecologic infections due
to C. sordellii and C. perfringens are rare, they progress so
rapidly that death often precedes diagnosis. Early conﬁrma-
tory diagnosis before the development of irreversible toxic
shock is critical for implementation of treatment measures
and support of epidemiologic investigations. However, pre-
sumptive diagnosis of CTS often relies on vague clinical
manifestations and is quite challenging. Also, the isolation
of Clostridium species is very diﬃcult. Only molecular
approaches guarantee identiﬁcation to the species level,
which is important for the selection of treatment as well as
fortheidentiﬁcationofthesourceofinfection[9].Generally,
several diagnostic assays for diﬀerent organisms have been
performed on the premortem biopsy samples for diﬀerential
diagnosis, but selecting individual assays in sequential order
can delay diagnosis and treatment as well as prolong
hospitalization. On the other hand, simultaneous testing by
individual assays for each organism can be expensive and
requires large volumes of patients’ samples, which is usually
diﬃcult to obtain, particularly for premortem diagnosis.
Even for the fatal cases, autopsies are often not performed
and the FFPE archival biopsy tissues are the only specimens
available. The microsphere assay addresses these issues and is
particularly useful for the rapid, accurate, and simultaneous
identiﬁcation of C. sordellii and C. perfringens in FFPE
tissues using only a small volume of starting material.
Another added advantage of this assay is the low cost. The
total cost of one test using this approach is less than 20
cents excluding costs for lab personnel and equipment. On
the other hand, the traditional PCR and automated DNA
sequencing methods cost at least $4 per test.
In this study, we compared conventional PCR assays
and microsphere assay results for various Clostridia stock6 Infectious Diseases in Obstetrics and Gynecology
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Figure 1: Identiﬁcation of C. sordellii and C. perfringens isolates
by the microsphere assay. Isolates 1–9: C. sordellii isolates. Isolates
10–18: C. perfringens isolates. Note higher MFI values/signals of C.
sordellii and C. perfringens probes for the respective isolates only,
indicating speciﬁcity of the probes.
strains (isolates) and FFPE tissue specimens from conﬁrmed
pregnancy or gynecologic procedure-associated CTS cases
to establish analytic sensitivity and speciﬁcity of the assay.
For the microsphere assays, direct DNA hybridization was
used in conjunction with short probes and TMAC buﬀer to
produce a stringent assay. Tetramethyl ammonium chloride
(TMAC) binds to the A-T rich regions of the genome and
signiﬁcantly reduces the diﬀerence in the melting temper-
ature between the A-T and G-C pairs. The phospholipase
C gene was targeted for the primers and probes because of
its presence in all types and strains of C. sordellii and C.
perfringens. Our results clearly demonstrate the high level of
clinical sensitivity and speciﬁcity of the microsphere assay
for the pathogens examined with 100% concordance with
the conventional PCR assay results for all clinical cases and
isolates. In addition, the microsphere assay was able to detect
mixedinfectionsofC.sordelliiandC.perfringensandshowed
no cross-reactivity with any other organisms tested. The
average MFI value for the C. sordellii cases was 1645 and
for C. perfringens cases was 1567. No correlation was seen
between the MFI values of C. sordellii and C. perfringens
cases and the duration of illness, type of infection (medical
abortion versus postpartum), IHC results, or any other
clinical feature.
We also performed histopathological evaluation and
Clostridia IHC on the tissues to deﬁne the pathology and
to detect Clostridial antigens in the areas of inﬂammation
and pathology. This information is particularly important
becauseClostridium species are present in the vaginal tract of
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Figure 2: Identiﬁcation of C. sordellii and C. perfringens in
conﬁrmed CTS cases by the microsphere assay. Cases 1–10: C.
sordellii cases conﬁrmed by conventional PCR and sequencing.
Cases 11–18: C. perfringens cases conﬁrmed by conventional PCR
and sequencing. No cross-reactivity was noted.
4–18% of healthy women [9, 30, 31]. We detected Clostridial
antigens by IHC in the areas of pathology, particularly in
the necrotic endometrial tissue in all conﬁrmed CTS cases,
except for 2 C. perfringens cases. In these IHC negative cases,
MFI values of the microsphere assay were quite good (above
1200) and the conventional PCR assays were also positive.
The reason for this discrepancy may be the lower sensitivity
of the IHC assay in comparison to the PCR and microsphere
assay or clearance of antigens by the host immune system.
5. Conclusions
The duplex microsphere assay is a rapid, sensitive, speciﬁc,
and cost-eﬀective method for the diagnosis of pregnancy-
associated CTS cases and oﬀers the advantage of simultane-
ouslytesting forC.sordellii andC.perfringensinFFPEtissues
usingalimitedamountofDNA.Theassaycanbeanexcellent
diagnostic tool for the identiﬁcation of mixed infections.
This technology also allows for further multiplexing of addi-
tional pathogens associated with toxic shock syndrome that
could be of great value for epidemiologic investigations. In
addition, the combination of the microsphere assay and IHC
for the analysis of Clostridial DNA and antigens together
in the tissues of fatal cases can provide an insight into the
disease pathogenesis, improve detection, and have important
implications for the diagnosis of CTS. Early recognition and
conﬁrmatory diagnosis of CTS, along with an aggressive
surgicalapproachandappropriateantimicrobialtherapy,canInfectious Diseases in Obstetrics and Gynecology 7
(a) (b)
Figure 3: (a) Abundant-gram-positive bacilli in the necrotic endometrial tissues (Gram’s stain).(b) Clostridialantigens (redstaining) inside
the inﬂammatory cells present in the necrotic endometrial tissues (IHC using polyclonal anti-clostridium species antibody).
decrease the mortality associated with this syndrome that
occurs primarily among young, otherwise healthy women.
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